Mortality in men admitted to hospital with acute urinary retention: Database analysis

British Medical Journal

Volumn 335, Issue 7631, 2007, Pages 1199-1202

  Armitage, James N ^a   Sibanda, Nokuthaba ^b   Cathcart, Paul J ^a   Emberton, Mark ^c   Van Der Meulen, Jan H P ^b  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; URINE RETENTION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; COMORBIDITY; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; URINARY RETENTION;

EID: 37249079601     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39377.617269.55     Document Type: Article

References (14)

1. Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC. Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol 2005;47:494-8.
2. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006;12:S122-8.
3. Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 2004;172:1390-3.
4. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007;51:199-203.
5. Cathcart P, van der Meulen J, Armitage J, Emberton M. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England. J Urol 2006;176:200-4.
6. McNeill SA, Hargreave TB. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol 2004;171:2316-20.
7. Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R, et al. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group. Eur Urol 2000;37:528-36.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 1987;40:373-83.
9. Nuttall M, van der Meulen J, Emberton M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 2006;59:265-73.
10. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8.
11. Pickard R, Emberton M, Neal DE. The management of men with acute urinary retention. BJU Int 1998;81:712-20.
12. Roberts SE, Goldacre MJ. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. BMJ 2003;327:771-5.
13. Roche JJW, Wenn RT, Sahota O, Moran CG. Effects of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005;331:1374.
14. Kirby RS, Kirby M. The urologist as an advocate of men's health: 10 suggested steps toward helping patients achieve better overall health. Urology 2005;66:52-6.